Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.818 USD | -0.09% | -4.30% | -8.63% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.